These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17174600)

  • 61. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L; Varela Román A; Pedreira Pérez M; Gómez Otero I; Virgós Lamela A; González-Juanatey JR
    Rev Esp Cardiol; 2006 Feb; 59(2):99-108. PubMed ID: 16540030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of angiotensin converting enzyme inhibition on renal function in the treatment of heart failure.
    Levine TB
    Clin Ther; 1989; 11(4):495-502. PubMed ID: 2673517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?
    Malinin AI; O'Connor CM; Dzhanashvili AI; Sane DC; Serebruany VL
    Am Heart J; 2003 Mar; 145(3):397-403. PubMed ID: 12660660
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypertension in the transplanted patient.
    Zeier M; Mandelbaum A; Ritz E
    Contrib Nephrol; 1998; 124():146-57; discussion 158-65. PubMed ID: 9761979
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.
    de Silva R; Nikitin NP; Witte KK; Rigby AS; Loh H; Nicholson A; Bhandari S; Clark AL; Cleland JG
    Eur J Heart Fail; 2007 Apr; 9(4):415-23. PubMed ID: 17174600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.